Cargando…

Enriching CCL3 in the Tumor Microenvironment Facilitates T cell Responses and Improves the Efficacy of Anti-PD-1 Therapy

Chemokines are key factors that influence the migration and maintenance of relevant immune cells into an infected tissue or a tumor microenvironment. Therefore, it is believed that the controlled administration of chemokines in the tumor microenvironment may be an effective immunotherapy against can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Tae Gun, Park, Hyo Jin, Moon, Jihyun, Lee, June Hyung, Ha, Sang-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263215/ https://www.ncbi.nlm.nih.gov/pubmed/34277113 http://dx.doi.org/10.4110/in.2021.21.e23

Ejemplares similares

Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
por: Lee, Hyun Tae, et al.
Publicado: (2017)

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
por: D’Alterio, Crescenzo, et al.
Publicado: (2019)

Midostaurin Modulates Tumor Microenvironment and Enhances Efficacy of Anti-PD-1 against Colon Cancer
por: Lai, Cheng-Ta, et al.
Publicado: (2022)

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment
por: Lecoq, Inés, et al.
Publicado: (2022)

High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma
por: Li, Lei, et al.
Publicado: (2018)

Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021)

Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy
por: Kim, Myeong Joon, et al.
Publicado: (2021)

Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma
por: Xu, Wenhao, et al.
Publicado: (2022)

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer
por: Wang, Yue, et al.
Publicado: (2018)

TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment
por: Park, Miso, et al.
Publicado: (2023)

Tumor immune microenvironment characterization and response to anti-PD-1 therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2015)

Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
por: Su, Yudong, et al.
Publicado: (2022)

Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients
por: Son, Seung-Myoung, et al.
Publicado: (2020)

YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironment
por: Kim, Dong Kwon, et al.
Publicado: (2022)

Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
por: Shi, Guilan, et al.
Publicado: (2022)

Analysis of the signal cross talk via CCL26 in the tumor microenvironment in osteosarcoma
por: Kawano, Masanori, et al.
Publicado: (2021)

The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5
por: Manfroi, Benoît, et al.
Publicado: (2021)

CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
por: Jin, Jiakang, et al.
Publicado: (2021)

CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis
por: Qian, Bin-Zhi, et al.
Publicado: (2011)

Bojungikki-Tang Improves Response to PD-L1 Immunotherapy by Regulating the Tumor Microenvironment in MC38 Tumor-Bearing Mice
por: Chun, Jaemoo, et al.
Publicado: (2022)

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
por: Kim, Young-Dae, et al.
Publicado: (2020)

The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
por: Barbai, Tamás, et al.
Publicado: (2015)

PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy
por: Huang, Min, et al.
Publicado: (2022)

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
por: Mukherjee, Debayan, et al.
Publicado: (2023)

Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer
por: Jin, Runsen, et al.
Publicado: (2020)

The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
por: Qian, Jiawen, et al.
Publicado: (2018)

Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells
por: Iida, Yuichi, et al.
Publicado: (2020)

Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC
por: Bullock, Bonnie L, et al.
Publicado: (2019)

EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
por: Hippe, Andreas, et al.
Publicado: (2020)

The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria
por: Lu, Tao, et al.
Publicado: (2016)

Seed- and Soil-Dependent Differences in Murine Breast Tumor Microenvironments Dictate Anti-PD-L1 IgG Delivery and Therapeutic Efficacy
por: Liu, Yan Ting, et al.
Publicado: (2021)

Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment
por: Lin, Wen-Jye, et al.
Publicado: (2014)

CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers
por: Gu, Qiang, et al.
Publicado: (2023)

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
por: Ng, Harry Ho Man, et al.
Publicado: (2020)

The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages
por: Pan, Baoyue, et al.
Publicado: (2023)

Tumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responses
por: Li, YaFei, et al.
Publicado: (2023)

Isoflavones-Enriched Soy Protein Prevents CCL(4)-Induced Hepatotoxicity in Rats
por: Sarhan, Nesma A. Z., et al.
Publicado: (2012)

PD-1 blockage combined with vaccine therapy can facilitate immune infiltration in tumor microenvironment of Lynch syndrome colon cancer
por: Ye, Kai, et al.
Publicado: (2022)

Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review
por: Wang, Nuo-Han, et al.
Publicado: (2022)

Regulation of PD-L1 expression in the tumor microenvironment
por: Yi, Ming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k89vo1avsqcdb14kse9kh634ps